Lower Urinary Tract Symptoms

Erectile Dysfunction

Obstructive Sleep Apneas Syndrom

Questionnaires to evaluate lower urinary tract symptoms and erectile dysfunction.

questionnaire passation

Damien JOLLY

Impact of Treatment of Obstructive Sleep Apnea Syndrome by Continuous Positive Airway Pressure Equipment at Night on the Lower Urinary Tract Symptoms and the Erectile Dysfunction

Evaluation of the lower urinary tract symptoms using "UrinarySymptom Profil"

Evaluation of the lower urinary tract symptoms using "International Index of Erectile Function"

CHU de Reims

Mecamylamine-Smoker

Mecamylamine-Non-Smoker

Placebo-Smoker

Placebo- Non-Smoker

Total

Sex: Female, Male

Race/Ethnicity, Customized

Veteran Status

Data were calculated as number of heavy drinking days (heavy drinking days is defined as 5 drinks on a single occasion for men and 4 for women) average during 90 days of treatment.

Mecamylamine- Smokers

Mecamylamine- Non-Smoker

Percent Heavy Drinking Days During Active Treatment Phase

The OCDS is a 14-item (rated 0-4), self-administered questionnaire for characterizing and quantifying the obsessive and compulsive cognitive aspects of craving and heavy (alcoholic) drinking, such as drinking-related thought, urges to drink, and the ability to resist those thoughts and urges. A higher total score indicates higher craving and ranges from 0-48.

Mecamylamine

Placebo

Self-report Weekly Craving Via Obsessive Compulsive Drinking Scale (OCDS)

Questionnaire of smoking urges (QSU). It has 32 questions that range from 1 to 7, there are 8 questions per sub-scale. The total range is 32 to 224. Each sub-scale ranges from 8- 56, with a higher score indicating higher craving.

Self-report Weekly Smoking Craving

self-report from only the smoking population for cigarettes per day

Self-report Average Number of Cigarettes Per Day

Mecamylamine- Smoker

Mecamylamine Non-Smoker

Placebo Smoker

Placebo Non-Smoker

Overall Study

Dr. Elizabeth Ralevski

Mecamylamine Smoker

Alcoholism

mecamylamine

VA Connecticut Healthcare System

Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients

Yale University

Depressive Disorder

Mecamylamine hydrochloride (Inversine)

Connecticut Mental Health Center

Nicotinic Receptor Augmentation of SSRI Antidepressants

A Double-Blind,Randomized,Placebo-Controlled Trial of Mecamylamine Hydrochloride for the Treatment of SSRI-Refractory Major Depressive Disorder.

Donaghue Medical Research Foundation